Aspen Aerogels (NYSE:ASPN) Releases FY 2025 Earnings Guidance

Aspen Aerogels (NYSE:ASPN) updated its FY 2025 earnings guidance on Thursday. The company provided EPS guidance of -4.150–4.050 for the period, compared to the consensus EPS estimate of -0.140. The company issued revenue guidance of $270.0 million-$280.0 million, compared to the consensus revenue estimate of $303.3 million.

Aspen Aerogels Stock Up 1.9%

Shares of ASPN opened at $7.33 on Thursday. The firm has a market cap of $603.70 million, a P/E ratio of -1.92 and a beta of 2.85. The stock has a 50 day simple moving average of $7.41 and a two-hundred day simple moving average of $6.78. The company has a debt-to-equity ratio of 0.34, a current ratio of 3.98 and a quick ratio of 3.31. Aspen Aerogels has a 1 year low of $4.16 and a 1 year high of $18.93.

Aspen Aerogels (NYSE:ASPN) last posted its quarterly earnings results on Thursday, August 7th. The construction company reported ($0.04) EPS for the quarter, topping the consensus estimate of ($0.12) by $0.08. The firm had revenue of $78.02 million for the quarter, compared to the consensus estimate of $72.53 million. Aspen Aerogels had a negative net margin of 78.53% and a positive return on equity of 2.92%. The business’s revenue was down 33.8% compared to the same quarter last year. During the same period last year, the firm posted $0.21 earnings per share. On average, analysts forecast that Aspen Aerogels will post 0.17 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts recently commented on the stock. Barclays cut shares of Aspen Aerogels from an “equal weight” rating to an “underweight” rating and lifted their target price for the stock from $7.00 to $16.00 in a research report on Monday, August 11th. Weiss Ratings restated a “sell (d)” rating on shares of Aspen Aerogels in a research report on Wednesday, October 8th. Finally, Canaccord Genuity Group decreased their price objective on Aspen Aerogels from $11.00 to $10.00 and set a “buy” rating on the stock in a report on Friday, August 8th. One research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, two have given a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $15.50.

Insider Buying and Selling

In related news, CAO Santhosh P. Daniel sold 4,410 shares of the company’s stock in a transaction on Tuesday, August 12th. The shares were sold at an average price of $7.31, for a total transaction of $32,237.10. Following the completion of the sale, the chief accounting officer directly owned 19,879 shares in the company, valued at $145,315.49. This represents a 18.16% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. 4.30% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Aspen Aerogels

Hedge funds have recently modified their holdings of the company. Osaic Holdings Inc. raised its stake in shares of Aspen Aerogels by 29.1% during the second quarter. Osaic Holdings Inc. now owns 10,615 shares of the construction company’s stock valued at $63,000 after acquiring an additional 2,390 shares during the last quarter. Caxton Associates LLP increased its holdings in Aspen Aerogels by 114.9% during the 2nd quarter. Caxton Associates LLP now owns 103,172 shares of the construction company’s stock valued at $611,000 after purchasing an additional 55,167 shares during the period. FORA Capital LLC increased its holdings in Aspen Aerogels by 138.2% during the 2nd quarter. FORA Capital LLC now owns 29,452 shares of the construction company’s stock valued at $174,000 after purchasing an additional 17,090 shares during the period. Tower Research Capital LLC TRC raised its position in Aspen Aerogels by 184.6% during the 2nd quarter. Tower Research Capital LLC TRC now owns 7,235 shares of the construction company’s stock valued at $43,000 after purchasing an additional 4,693 shares during the last quarter. Finally, Voleon Capital Management LP lifted its holdings in Aspen Aerogels by 464.8% in the 2nd quarter. Voleon Capital Management LP now owns 248,839 shares of the construction company’s stock worth $1,473,000 after buying an additional 204,779 shares during the period. Hedge funds and other institutional investors own 97.64% of the company’s stock.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.